A Novel Vaccine for The Novel Corona Virus |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.11, No. 3)Publication Date: 2020-12-15
Authors : Robert O Dillman; Gabriel I Nistor; Aleksandra J Poole; Candace Hsieh; Hans S Keirstead;
Page : 225-226
Keywords : SinoVac; Sinopharm; CanSino; AstraZeneca; Pathogen;
Abstract
A high level of “herd immunity” will be necessary to control the current COVID-19 pandemic caused by the SARS-CoV-2 virus. Herd immunity is achieved when a substantial majority of a population becomes immune to a disease, making the spread of the pathogen unlikely. Herd immunity will eventually be achieved by the combination of individuals who recover from active infection, and preventive immunization of unaffected individuals. Because of the extensive morbidity and mortality associated with active infection, preventive vaccination is the preferred strategy.
Other Latest Articles
- Prospects and Potential of Tourism in Chinta Valley, Bhaderwah, Doda, Jammu and Kahmir
- Retinal Complications in Indians with Type 2 Diabetics
- Role of MGNREGA Scheme in Women Empowerment in India An Analysis
- An Exploratory Study to Assess the Usage of Mobile Phone and Attitude Regarding Mobile Phone Usage among B.Sc Nursing Students in Selected College of Nursing in Chennai
- Influence of Table of Specification on the Construction of Ordinary Level Physics Examination in Cameroon
Last modified: 2023-07-20 21:34:08